User Posts: admin3
0
Big Pharma: Life-Savers or Profiteers?
0

If you would like this piece read to you, just click above As many of you know, I’m not one to sit on the fence, and I have very strong personal ...

0
Beating Cancer at Its Own Game
0

Being hospitalized can be boring. Necessary, certainly, but boring all the same. They say that “time flies when you’re having fun,” but it drags by as ...

0
The Value of Time in Cancer Care
0

From left: DAYNA HARDEE, RN, and ANNA JIMENEZ, M.S.N., RN, CCRN-K, CNML PHOTOS BY JACKIE CEJAAs a child, Dayna Hardee, RN, understood the value of time. She ...

0
Tecvayli Effective in BCMA-Pretreated R/R Multiple Myeloma
0

Patients should have discussions about Tecvayli as treatment after previous BCMA-directed therapy with their doctors, an expert said.Treatment with Tecvayli ...

0
Blood Sugar Levels May Affect Cancer Outcomes in Patients With Diabetes
0

"The inflammation and tumor markers could be causing the varying blood sugar, or it could be vice-versa,' an expert told CURE®. "It's kind of a vicious ...

0
Applying Positive Affirmations as My Response to Colon Cancer
0

Tom Ziglar once said, “The most powerful story in the world is the story you tell yourself because it determines your thinking, your thinking determines ...

0
Olivia Munn Has Hysterectomy After Breast Cancer, Michael McDonald’s Lesson from Wife’s Cancer and More
0

Olivia Munn, American actress, opened up about her tough decision to undergo a hysterectomy after breast cancer.Olivia Munn revealed that she underwent a ...

0
FDA Expedites Review of Petosemtamab in Head and Neck Cancer
0

A novel treatment for patients with head and neck cancers has received a breakthrough therapy designation from the FDA.The Food and Drug Administration ...

0
FDA Approves Imdelltra For Advanced SCLC
0

Imdlltra has been FDA approved for certain patients with advanced small cell lung cancer. The Food and Drug Administration (FDA) approved Imdelltra ...

0
Erleada, ADT ‘One-Two Punch’ in Prostate Cancer Treatment
0

Postsurgical treatment with androgen deprivation therapy and Erleada (apalutamide) resulted in a 100% 24-month biochemical recurrence (BCR)-free rate among ...

User Deals: admin3
Browsing All Comments By: admin3
CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart